Search Results 141-150 of 16326 for Conduction

1. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

   Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

2. A Study to Evaluate the Effectiveness and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

   * ECG evidence of acute ischemia or active conduction system abnormalities * Prior treatment with hematopoietic growth factors, transfusions of blood or ...

3. Mayo Clinic Restores Disrupted Heartbeat with Regenerative Intervention

   Muscle damage following a heart attack may disrupt normal heart conduction, resulting in a condition known as cardiac dyssynchrony. Current therapy uses ...

4. A Study of Beta-Blockers for the Prevention of Acute Worsening of Chronic Obstructive Pulmonary Disease - Mayo Clinic

   Patients on other cardiac medications known to cause atrioventricular (AV) node conduction delays such as amiodarone, digoxin, and calcium channel blockers ...

5. Vagus nerve stimulation - Mayo Clinic

   Learn more about this procedure that may be used to treat epilepsy and other neurological conditions when other treatments haven't worked.

6. Electromyography (EMG) - Doctors & Departments - Mayo Clinic

   ... conduction study, Neuromuscular ultrasound, Facet joint injection, Cyst ... Areas of focus: EEG, Botox injection, Electromyography, Nerve conduction ...

7. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Severe conduction disturbances; Angina pectoris requiring therapy; Left ventricular ejection fraction (LVEF) < 50% by MUGA or echocardiogram; QTcF interval > ...

8. Premature ventricular contractions (PVCs) - Symptoms & causes - Mayo Clinic

   PVCs are extra heartbeats that can make the heart beat out of rhythm. They are very common and may not be a concern. Learn when treatment is needed.

9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   - Clinically significant arrhythmias or conduction block (premature atrial contractions [PACs], premature ventricular contractions [PVCs], rate controlled

10. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    Clinically significant conduction abnormalities or arrhythmias;. NOTE: Any clinically significant ECG assessments should be reviewed by the site cardiologist ...